Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Published Articles Life Sciences & Pharma From Bench to Bedside: Academic-to-Industry Translation in European Biopharma August 27, 2025
Executive Insights Life Sciences & Pharma Combination Vaccines: Converting Clinical Promise Into Commercial Scale July 11, 2025
Executive Insights Life Sciences & Pharma Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies April 17, 2025
Executive Insights Life Sciences & Pharma Radiotherapeutics on the Rise: Addressing Supply Chain Complexity April 7, 2025
Smart Chart Life Sciences & Pharma Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations March 10, 2025
